Literature DB >> 12747695

In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays.

S E Murinda1, K A Rashid, R F Roberts.   

Abstract

Gram-positive bacterial bacteriocins (nisin and pediocin) and gram-negative bacterial bacteriocins (colicins [Col] E1, E3, E6, E7, and K) were evaluated for cytotoxicity against cultured simian virus 40-transfected human colon (SV40-HC) and Vero monkey kidney (Vero) cells. Bacteriocin-treated cells were assessed for viability by trypan blue staining. Monolayers of SV40-HC and Vero cells were cultured in tissue culture plates (35 degrees C, 10% CO2 in humidified air) with the use of Dulbecco's modified Eagle's medium supplemented with 10% (vol/vol) calf serum. Actively growing cells in the log phase (ca. 10(4) cells per ml) were treated with individual partially purified bacteriocin preparations at 170, 350, and 700 activity units per ml. Duplicate culture plates for each bacteriocin treatment and untreated controls were withdrawn after 16, 32, and 48 h of incubation. Cells were dissociated with trypsin and treated with trypan blue and were then counted in a hemocytometer with the use of a phase-contrast microscope. Viability assays indicated dose-dependent toxicity for some bacteriocins. Nisin, pediocin, and Col E6 were the most cytotoxic bacteriocins; SV40-HC cells demonstrated greater sensitivity than Vero cells did. Some bacteriocins can be toxic to mammalian cells; therefore, bacteriocins intended for use as biopreservatives must be evaluated for toxicity to mammalian cells and for other toxicities. Col E1, Col E3, Col E7, and Col K demonstrated little toxicity at the activities tested, indicating that they are safe and thus have potential for use as food biopreservatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747695     DOI: 10.4315/0362-028x-66.5.847

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  18 in total

1.  Investigation of the cytotoxicity of antimicrobial peptide P40 on eukaryotic cells.

Authors:  Rodrigo A Vaucher; Mario L Teixeira; Adriano Brandelli
Journal:  Curr Microbiol       Date:  2009-08-29       Impact factor: 2.188

Review 2.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

3.  Characterization, Toxicity, and Optimization for the Growth and Production of Bacteriocin-like Substances by Lactobacillus curvatus.

Authors:  Graciele Daiana Funck; Juliana de Lima Marques; Guilherme da Silva Dannenberg; Claudio Eduardo Dos Santos Cruxen; Carla Pohl Sehn; Marina Prigol; Márcia Rósula Poetini Silva; Wladimir Padilha da Silva; Ângela Maria Fiorentini
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

4.  Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.

Authors:  Francisco R Fields; Giorgia Manzo; Charlotte K Hind; Jeshina Janardhanan; Ilona P Foik; Phoebe Do Carmo Silva; Rashna D Balsara; Melanie Clifford; Henry M Vu; Jessica N Ross; Veronica R Kalwajtys; Alejandro J Gonzalez; Tam T Bui; Victoria A Ploplis; Francis J Castellino; Albert Siryaporn; Mayland Chang; J Mark Sutton; A James Mason; Shaun Lee
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

Review 5.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

6.  Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.

Authors:  Francisco R Fields; Katelyn E Carothers; Rashna D Balsara; Victoria A Ploplis; Francis J Castellino; Shaun W Lee
Journal:  J Antibiot (Tokyo)       Date:  2018-02-20       Impact factor: 2.649

Review 7.  Mechanisms of Candida Resistance to Antimycotics and Promising Ways to Overcome It: The Role of Probiotics.

Authors:  Konstantin A Demin; Aleksandr G Refeld; Anna A Bogdanova; Evgenya V Prazdnova; Igor V Popov; Olga Yu Kutsevalova; Alexey M Ermakov; Anzhelica B Bren; Dmitry V Rudoy; Vladimir A Chistyakov; Richard Weeks; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-18       Impact factor: 4.609

8.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

9.  MDcons: Intermolecular contact maps as a tool to analyze the interface of protein complexes from molecular dynamics trajectories.

Authors:  Safwat Abdel-Azeim; Edrisse Chermak; Anna Vangone; Romina Oliva; Luigi Cavallo
Journal:  BMC Bioinformatics       Date:  2014-05-06       Impact factor: 3.169

10.  Expression of bacteriocin divercin AS7 in Escherichia coli and its functional analysis.

Authors:  Agnieszka K Olejnik-Schmidt; Marcin T Schmidt; Anna Sip; Tomasz Szablewski; Włodzimierz Grajek
Journal:  Ann Microbiol       Date:  2013-11-27       Impact factor: 2.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.